Abstract
With the advent of time, many microbial strains have developed resistance against various antibiotics. The treatment of infectious diseases gets more difficult when the bacteria form multidrug-resistant biofilms. Bacteria like Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, and Listeria monocytogenes are capable of forming biofilm in vitro and cause several chronic infections like inflammatory bowel disease, colorectal cancer, catheter infection, and listeriosis. As these microorganisms are difficult to eliminate with antibiotics, there is an insistent need for alternative sources of antimicrobial therapies. Plants are one of the major sources of chemical compounds with higher therapeutic potential since many years. A large spectrum of plant-derived compounds and their secondary metabolites have antimicrobial activity and are being widely studied for their antimicrobial, anti-inflammatory, and antiviral properties. This chapter focuses on the various antibacterial properties of these plant-derived compounds and their activity alone or in combination with other compounds or antibiotics as possible antibacterial agents. It also focuses on the nanoencapsulation of these compounds to improve their bioavailability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78:119–146
Davey ME, O’toole GA (2000) Microbial biofilms: from ecology to molecular genetics. Mol Biol Rev 64(4):847–867
de Lencastre H, Oliveira D, Tomasz A (2007) Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol 10(5):428–435
European Centre for Disease Prevention and Control Antimicrobial Resistance Interactive (EARS-Net) Database (2013) http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/Database.aspx. Accessed 15 Feb 2017
World Health Organization (2014) Global tuberculosis report 2014. WHO, Geneva. http://www.who.int/tb/publications/global_report/en/. Accessed 12 Jan 2017
Van Boeckel TP, Gandra S, Ashok A et al (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14(8):742–750
Llor C, Bjerrum L (2014) Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 5(6):229–241
Tiwari BK, Valdramidis VP, O’Donnell CP et al (2009) Application of natural antimicrobials for food preservation. J Agric Food Chem 57(14):5987–6000
Dorman HJ, Deans SG (2000) Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 88(2):308–316
Cocchiara J, Letizia CS, Lalko J et al (2005) Fragrance material review on cinnamaldehyde. Food Chem Toxicol 45(6):867–923
Tadros T, Izquierdo P, Esquena J, Solans C (2004) Formation and stability of nano-emulsions. Adv Colloid Interf Sci 108–109:303–318
Center for Disease Control and Prevention, Office of Infectious Disease (2013) Antibiotic resistance threats in the United States. http://www.cdc.gov/drugresistance/threat-report-2013. Accessed 28 Jan 2017
Byarugaba DK (2005) Antimicrobial resistance and its containment in developing countries. In: Gould IM, van der Meer JWM (eds) Antibiotic policies: theory and practice. Springer, New York
Center for Disease Dynamics, Economics & Policy (2015) State of the world’s antibiotics, 2015. CDDEP: Washington, DC. http://cddep.org/publications/state_worlds_antibiotics_2015#sthash.5RFGA8Oh.dpb. Accessed 17 Feb 2017
Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406(6797):775–781
World Health Organization (2016) Antibiotic resistance fact sheet 2016. WHO, New York. http://www.who.int/mediacentre/factsheets/fs194/en/. Accessed 12 Jan 2017
Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 40(4):277–283
Lade H, Paul D, Kweon JH (2014) Quorum quenching mediated approaches for control of membrane biofouling. Int J Biol Sci 10(5):550–565
Tannières M, Lang J, Barnier C et al (2017) Quorum-quenching limits quorum-sensing exploitation by signal-negative invaders. Sci Rep 7:40126
Petrova OE, Sauer K (2016) Escaping the biofilm in more than one way: desorption, detachment or dispersion. Curr Opin Microbiol 30:67–78
Costerton JW, Lewandowski Z, Caldwell DE et al (1995) Microbial Biofilms. Annu Rev Microbiol 49:711–745
Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8(9):881–890
Fletcher M, Loeb GI (1979) Influence of substratum characteristics on the attachment of a marine pseudomonad to solid surfaces. Appl Environ Microbiol 37(1):67–72
Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2(2):95–108
Korber DR, Lawrence JR, Sutton B, Caldwell DE (1989) Effect of laminar flow velocity on the kinetics of surface recolonization by Mot+ and Mot− Pseudomonas fluorescens. Microb Ecol 18(1):1–19
Prüß BM (2017) Involvement of two-component signaling on bacterial motility and biofilm development. J Bacteriol 199(18):e00259–e00217
Kokare CR, Chakraborty S, Khopade AN, Mahadik KR (2009) Biofilm: importance and application. Indian J Biotechnol 8(2):159–169
Stoodley P, Purevdorj-Gage B, Costerton JW (2005) Clinical significance of seeding dispersal in biofilms: a response. Microbiology 151(11):3453–3453
Myllymaa K, Levon J, Tiainen VM et al (2013) Formation and retention of staphylococcal biofilms on DLC and its hybrids compared to metals used as biomaterials. Colloids Surf B Biointerfaces 101:290–297
Karimi A, Karig D, Kumar A, Ardekani AM (2015) Interplay of physical mechanisms and biofilm processes: review of microfluidic methods. Lab Chip 15(1):23–42
Bendinger B, Rijnaarts HH, Altendorf K, Zehnder AJ (1993) Physicochemical cell surface and adhesive properties of coryneform bacteria related to the presence and chain length of mycolic acids. Appl Environ Microbiol 59(11):3973–3977
Ramli NS, Eng Guan C, Nathan S, Vadivelu J (2012) The effect of environmental conditions on biofilm formation of Burkholderia pseudomallei clinical isolates. PLoS One 7(9):e44104
Liu R, Zhu J, Yu Z et al (2014) Molecular analysis of long-term biofilm formation on PVC and cast iron surfaces in drinking water distribution system. J Environ Sci 26(4):865–874
Fletcher M (1988) Attachment of Pseudomonas fluorescens to glass and influence of electrolytes on bacterium-substratum separation distance. J Bacteriol 170(5):2027–2030
Cowan MM, Warren TM, Fletcher M (1991) Mixed species colonization of solid surfaces in laboratory biofilms. Biofouling 3(1):23–34
Hanlon GW, Denyer SP, Hodges NA et al (2004) Biofilm formation and changes in bacterial cell surface hydrophobicity during growth in a CAPD model system. J Pharm Pharmacol 56(7):847–854
Davies DG, Geesey GG (1995) Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl Environ Microbiol 61:860–867
Prigent-Combaret C, Vidal O, Dorel C, Lejeune P (1999) Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol 181:5993–6002
Pulcini E (2001) The effects of initial adhesion events on the physiology of Pseudomonas aeruginosa. Dissertation, Montana State University
Imamura Y, Chandra J, Mukherjee PK et al (2008) Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother 52(1):171–182
Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33(8):1387–1392
Harries AD, Dye C (2006) Tuberculosis. Ann Trop Med Parasitol 100(5–6):415–431
Bhan MK, Bahl R, Bhatnagar S (2005) Typhoid and paratyphoid fever. Lancet 366(9487):749–762
Adcox HE, Vasicek EM, Dwivedi V et al (2016) Salmonella extracellular matrix components influence biofilm formation and gallbladder colonization. Infect Immun 84(11):3243–3251
Atkinson W (2012) Epidemiology and prevention of vaccine- preventable diseases, 12th edn. Public Health Foundation, Washington, DC
World Health Organization (2006) Diphtheria vaccine. Wkly Epidemiol Rec 81(3):24–32
Finkelstein RA (1996) Cholera, Vibrio cholerae O1 and O139, and other pathogenic vibrios. In: Baron S (ed) Medical microbiology, 4th edn. University of Texas, Galveston. Available online http://gsbs.utmb.edu/microbook/ch024.htm
Myers AL, Hall M, Williams DJ et al (2013) Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J 32(7):736–740
Center for Disease Control and Prevention (2016) Necrotizing fasciitis: a rare disease, especially for the healthy. https://www.cdc.gov/features/necrotizingfasciitis/. Accessed 20 Feb 2017
Mosier DA (1997) Bacterial pneumonia. Vet Clin North Am Food Anim Pract 13(3):483–493
Marijon E, Mirabel M, Celermajer DS, Jouven X (2012) Rheumatic heart disease. Lancet 379(9819):953–964
Baron S (1996) Medical microbiology, 4th edn. University of Texas Medical Branch, Galveston
Cheng AC, Currie BJ (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18(2):383–416
Conrads G, de Soet JJ, Song L et al (2014) Comparing the cariogenic species Streptococcus sobrinus and S. mutans on whole genome level. J Oral Microbiol 6:26189
Smiley ST (2008) Immune defense against pneumonic plague. Immunol Rev 225(1):256–271
Singh M, Kaur M, Silakari O (2014) Flavones: an important scaffold for medicinal chemistry. Eur J Med Chem 84:206–239
Nijveldt RJ, van Nood E, van Hoorn DE et al (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74(4):418–425
Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. Sci World J 2013:162750
Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12(4):564–582
Bag A, Chattopadhyay RR (2014) Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli. Nat Prod Res 28(16):1280–1283
Jain PK, Joshi H (2012) Coumarin: chemical and pharmacological profile. J Appl Pharm Sci 2(6):236–240
Burt S (2004) Essential oils: their antibacterial properties and potential applications in foods—a review. Int J Food Microbiol 94(3):223–253
Cushnie TP, Cushnie B, Lamb AJ (2014) Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Int J Antimicrob Agents 44(5):377–386
Upadhyay A, Upadhyaya I, Kollanoor-Johny A, Venkitanarayanan K (2014) Combating pathogenic microorganisms using plant-derived antimicrobials: a mini-review of the mechanistic basis. Biomed Res Int 2014:761741
Daglia M (2012) Polyphenols as antimicrobial agents. Curr Opin Biotechnol 23(2):174–181
Pistelli L, Giorgi I (2012) Antimicrobial properties of flavonoids. In: Patra A (ed) Dietary phytochemicals and microbes. Springer, Dordrecht
Borges A, Abreu AC, Dias C et al (2016) New perspectives on the use of phytochemicals as an emergent strategy to control bacterial infections including biofilms. Molecules 21(7):E877
Cushnie TT, Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26(5):343–356
Rentzsch M, Wilkens A, Winterhalter P (2009) Non-flavonoid phenolic compounds. In: Moreno-Arribas MV, Polo C (eds) Wine chemistry and biochemistry. Springer, New York
Saleem M, Nazir M, Ali MS et al (2010) Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 27(2):238–254
Scalbert A (1991) Antimicrobial properties of tannins. Phytochemistry 30(12):3875–3883
Akiyama H, Fujii K, Yamasaki O et al (2001) Antibacterial action of several tannins against Staphylococcus aureus. J Antimicrob Chemother 48(4):487–491
Khanbabaee K, van Ree T (2001) Tannins: classification and definition. Nat Prod Rep 18(6):641–649
Majed F, Rashid S, Khan AQ et al (2015) Tannic acid mitigates the DMBA/croton oil-induced skin cancer progression in mice. Mol Cell Biochem 399(1–2):217–228
Kayser O, Kolodziej H (1999) Antibacterial activity of simple coumarins: structural requirements for biological activity. Z Naturforsch 54(3–4):169–174
Bakkali F, Averbeck S, Averbeck D, Idaomar M et al (2008) Biological effects of essential oils–a review. Food Chem Toxicol 46(2):446–475
Kavanaugh NL, Ribbeck K (2012) Selected antimicrobial essential oils eradicate Pseudomonas spp. and Staphylococcus aureus biofilms. Appl Environ Microbiol 78(11):4057–4061
Swamy MK, Akhtar MS, Sinniah UR (2016) Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid Based Complement Alternat Med 2016:3012462
Nazzaro F, Fratianni F, De Martino L et al (2013) Effect of essential oils on pathogenic bacteria. Pharmaceuticals 6(12):1451–1474
Levinson W, Jawetz E (2002) Medical microbiology and immunology: examination and board review, 7th edn. Lange Medical Books/McGraw-Hill, New York
Adwan G, Abu-Shanab B, Adwan K (2010) Antibacterial activities of some plant extracts alone and in combination with different antimicrobials against multidrug-resistant Pseudomonas aeruginosa strains. Asian Pac J Trop Med 3(4):266–269
Liang R, Xu S, Shoemaker CF et al (2012) Physical and antimicrobial properties of peppermint oil nanoemulsions. J Agric Food Chem 60(30):7548–7555
Chifiriuc C, Grumezescu V, Grumezescu AM et al (2012) Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett 7(1):209
Elumalai EK, Ramachandran M, Thirumalai T, Vinothkumar P (2011) Antibacterial activity of various leaf extracts of Merremia emarginata. Asian Pac J Trop Biomed 1(5):406–408
Zakaria Z, Sreenivasan S, Mohamad M (2007) Antimicrobial activity of Piper ribesoides root extract against Staphylococcus aureus. J Appl Biol Sci 1(3):87–90
Wu Y, Luo Y, Wang Q (2012) Antioxidant and antimicrobial properties of essential oils encapsulated in zein nanoparticles prepared by liquid–liquid dispersion method. LWT Food Sci Technol 48(2):283–290
Zhang L, Pornpattananangku D, Hu CM, Huang CM et al (2010) Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17(6):585–594
Sahu P, Das D, Mishra VK et al (2017) Nanoemulsion: a novel eon in cancer chemotherapy. Mini Rev Med Chem 17(18):1778–1792
Nirmal C, Puvanakrishnana R (1996) Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochem Pharmacol 51(1):47–51
Capek I (2004) Degradation of kinetically-stable o/w emulsions. Adv Colloid Interf Sci 107(2–3):125–155
Ghaderi L, Moghimi R, Aliahmadi A et al (2017) Development of antimicrobial nanoemulsion-based delivery systems against selected pathogenic bacteria using a thymol-rich thymus daenensis essential oil. J Appl Microbiol 123(4):832–840
Gupta A, Badruddoza AZM, Doyle PS (2017) A general route for nanoemulsion synthesis using low-energy methods at constant temperature. Langmuir 33(28):7118–7123
Lawrence MJ, Rees GD (2000) Micro emulsion-based media as novel drug delivery system. Adv Drug Deliv Rev 45(1):89–121
Wang L, Mutch KJ, Eastoe J et al (2008) Nanoemulsions prepared by a two-step low-energy process. Langmuir 24(12):6092–6099
von Corswant C, Thorén P, Engström S (1998) Triglyceride-based micro emulsion from intervenes administration of sparingly soluble substances. J Pharm Sci 87(2):200–208
Taylor PW, Hamilton-Miller JMT, Paul D, Stapleton PD (2005) Antimicrobial properties of green tea catechins. Food Sci Technol Bull 2:71–81
Vidigal PG, Müsken M, Becker KA et al (2014) Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm. PLoS One 9(4):e92876
Jeon J, Kim JH, Lee CK et al (2014) The antimicrobial activity of (−)-epigallocatehin-3-gallate and green tea extracts against Pseudomonas aeruginosa and Escherichia coli isolated from skin wounds. Ann Dermatol 26(5):564–569
Chakrawarti L, Agrawal R, Dang S et al (2016) Therapeutic effects of EGCG: a patent review. Expert Opin Ther Pat 26(8):907–916
Serra DO, Mika F, Richter AM, Hengge R et al (2016) The green tea polyphenol EGCG inhibits E. coli biofilm formation by impairing amyloid curlifibre assembly and downregulating the biofilm regulator CsgD via the σE -dependent sRNA RybB. Mol Microbiol 101(1):136–151
Zhao WH, Hu ZQ, Okubo S et al (2001) Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45(6):1737–1742
Hemaiswarya S, Kruthiventi AK, Doble M et al (2008) Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15(8):639–652
Fangueiro JF, Calpena AC, Clares B et al (2016) Biopharmaceutical evaluation of epigallocatechingallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. Int J Pharm 502(1):161–169
Lin YH, Feng CL, Lai CH et al (2014) Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo. Sci Technol Adv Mater 15(4):045006
Tyagi P, Singh M, Kumari H et al (2015) Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One 10(3):e0121313
Rai D, Singh JK, Roy N, Panda D (2008) Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J 410(1):147–155
Chang C-Y, Krishnan T, Wang H et al (2014) Non-antibiotic quorum sensing inhibitors acting against N-acyl homoserine lactone synthase as druggable target. Sci Rep 4:7245
Packiavathy IA, Priya S, Pandian SK, Ravi AV et al (2014) Inhibition of biofilm development of uropathogens by curcumin–an anti-quorum sensing agent from Curcuma longa. Food Chem 148:453–460
Moghadamtousi SZ, Kadir HA, Hassandarvish P et al (2014) A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int 2014:186864
Mun SH, Joung DK, Kim YS et al (2013) Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine 20(8–9):714–718
Hatamie S, Nouri M, Karandikar SK et al (2012) Complexes of cobalt nanoparticles and polyfunctional curcumin as antimicrobial agents. Mater Sci Eng C 32(2):92–97
Krausz AE, Adler BL, Cabral V et al (2015) Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine 11(1):195–206
Loo CY, Rohanizadeh R, Young PM et al (2015) Combination of silver nanoparticles and curcumin nanoparticles for enhanced anti-biofilm activities. J Agric Food Chem 64(12):2513–2522
Hwang D, Lim YH (2015) Resveratrol antibacterial activity against Escherichia coli is mediated by Z-ring formation inhibition via suppression of FtsZ expression. Sci Rep 5:10029
Joung DK, Choi SH, Kang OH et al (2015) Synergistic effects of oxyresveratrol in conjunction with antibiotics against methicillin-resistant Staphylococcus aureus. Mol Med Rep 12(1):663–667
Jeon YO, Lee JS, Lee HG (2016) Improving solubility, stability, and cellular uptake of resveratrol by nanoencapsulation with chitosan and γ-poly (glutamic acid). Colloids Surf B Biointerfaces 147:224–233
Amalaradjou MA, Narayanan A, Baskaran SA, Venkitanarayanan K et al (2010) Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli. J Urol 184(1):358–363
Nuryastuti T, van der Mei HC, Busscher HJ et al (2009) Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis. Appl Environ Microbiol 75(21):6850–6855
Niu C, Afre S, Gilbert ES (2006) Sub-inhibitory concentrations of cinnamaldehyde interfere with quorum sensing. Lett Appl Microbiol 43(5):489–494
Nostro A, Scaffaro R, D’Arrigo M et al (2012) Study on carvacrol and cinnamaldehyde polymeric films: mechanical properties, release kinetics and antibacterial and antibiofilm activities. Appl Microbiol Biotechnol 96(4):1029–1038
Gomes C, Moreira RG, Castell-Perez E (2011) Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications. J Food Sci 76(2):16–24
Nostro A, Sudano Roccaro A, Bisignano G et al (2007) Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Med Microbiol 56(4):519–523
Burt SA, Ojo-Fakunle VT, Woertman J, Veldhuizen EJ (2014) The natural antimicrobial carvacrol inhibits quorum sensing in Chromobacterium violaceum and reduces bacterial biofilm formation at sub-lethal concentrations. PLoS One 9(4):e93414
Wang Q, Gong J, Huang X et al (2009) In vitro evaluation of the activity of microencapsulated carvacrol against Escherichia coli with K88 pili. J Appl Microbiol 107(6):1781–1788
Pérez-Conesa D, Cao J, Chen L et al (2011) Inactivation of Listeria monocytogenes and Escherichia coli O157:H7 biofilms by micelle-encapsulated eugenol and carvacrol. J Food Prot 74(1):55–62
Miladi H, Zmantar T, Kouidhi B et al (2017) Synergistic effect of eugenol, carvacrol, thymol, p-cymene and γ-terpinene on inhibition of drug resistance and biofilm formation of oral bacteria. Microb Pathog 112:156–163
Iannitelli A, Grande R, Di Stefano A et al (2011) Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm. Int J Mol Sci 12(8):5039–5051
Zodrow KR, Schiffman JD, Elimelech M (2012) Biodegradable polymer (PLGA) coatings featuring cinnamaldehyde and carvacrol mitigate biofilm formation. Langmuir 28(39):13993–13999
Evans JD, Martin SA (2000) Effects of thymol on ruminal microorganisms. Curr Microbiol 41(5):336–340
Lambert RJ, Skandamis PN, Coote PJ, Nychas GJ et al (2001) A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol 91(3):453–462
Karpanen TJ, Worthington T, Hendry ER et al (2008) Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J Antimicrob Chemother 62(5):1031–1036
Zhou F, Ji B, Zhang H et al (2007) The antibacterial effect of cinnamaldehyde, thymol, carvacrol and their combinations against the foodborne pathogen Salmonella typhimurium. J Food Saf 27(2):124–133
Liolios CC, Gortzi O, Lalas S et al (2009) Liposomal incorporation of carvacrol and thymol isolated from the essential oil of Origanum dictamnus L. and in vitro antimicrobial activity. Food Chem 112(1):77–83
Gill AO, Holley RA (2004) Mechanisms of bactericidal action of cinnamaldehyde against Listeria monocytogenes and of eugenol against L. monocytogenes and Lactobacillus sakei. Appl Environ Microbiol 70(10):5750–5755
Zhou L, Zheng H, Tang Y et al (2013) Eugenol inhibits quorum sensing at sub-inhibitory concentrations. Biotechnol Lett 35(4):631–637
Zhang P, Zhang E, Xiao M et al (2013) Enhanced chemical and biological activities of a newly biosynthesized eugenol glycoconjugate, eugenol α-D-glucopyranoside. Appl Microbiol Biotechnol 97(3):1043–1050
Narayanan A, Neera M, Ramana KV (2013) Synergized antimicrobial activity of eugenol incorporated polyhydroxy butyrate films against food spoilage microorganisms in conjunction with pediocin. Appl Biochem Biotechnol 170(6):1379–1388
Ghosh V, Mukherjee A, Chandrasekaran N (2014) Eugenol-loaded antimicrobial nanoemulsion preserves fruit juice against, microbial spoilage. Colloids Surf B Biointerfaces 114:392–397
LiveLeaf, Inc (2017) Method of killing a bacteria with a plant-based biocidal solution. USPatent 9, 636, 361, 2 May 2017
Slippery Rock University Foundation, Inc (2017) Methods of treating infectious diseases. US Patent 9,545,386, 17 Jan 2017
LiveLeaf, Inc (2015) Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide. US Patent 9,192,635, 24 Nov 2015
The Hong Kong Polytechnic University (2015) Flavonoid dimers and their use. US Patent 8,980,848, 17 March 2015
Liveleaf, Inc (2014) Combining a polyphenol with hydrogen peroxide to treat or prevent a bacterial infection. US Patent 20140072660, 13 March 2014
Emory University (2009) Triptolide analogs for the treatment of autoimmune and inflammatory disorders. US Patent 7,557,139, 7 July 2009
Gubarev MJ, Enioutina EY (2000) Method to enhance innate immunity defense mechanisms by treatment with plant-derived alkaloids. US Patent 6,149,912, 21 Nov 2000
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gaur, G., Raj, U.L., Dang, S., Gupta, S., Gabrani, R. (2018). Plant-Derived Drug Molecules as Antibacterial Agents. In: Rani, V., Yadav, U. (eds) Functional Food and Human Health. Springer, Singapore. https://doi.org/10.1007/978-981-13-1123-9_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-1123-9_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1122-2
Online ISBN: 978-981-13-1123-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)